Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trialJakob M. Riedl, Armin Gerger, Herbert Stöger et al.|Therapeutic Advances in Medical Oncology|2021Cited by 10
Feasibility and workflow analysis of confocal microscopy in robot‐assisted prostatectomyKristijan Skok, Johannes Mischinger, Lukas Scheipner et al.|British Journal of Urology|2026Cited by 1
Abstract CT130: Molecular-biological tumor profiling for drug treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage Phase II individualized cancer treatment studySamantha Perakis, Armin Gerger, Peter Ulz et al.|Cancer Research|2019Cited by 0
1938P Profiling of circulating tumour DNA for treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage phase II individualized cancer treatment trialArmin Gerger, Ellen Heitzer, Andrea Berghold et al.|Annals of Oncology|2020Cited by 0
Abstract CT130: Molecular-biological tumor profiling for drug treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage Phase II individualized cancer treatment studySamantha Perakis, Armin Gerger, Peter Ulz et al.|Clinical Trials|2019Cited by 0